Free Trial
LON:OPTI

OptiBiotix Health (OPTI) Share Price, News & Analysis

OptiBiotix Health logo
GBX 10 -0.25 (-2.44%)
As of 09/12/2025 11:06 AM Eastern

About OptiBiotix Health Stock (LON:OPTI)

Key Stats

Today's Range
10
10.50
50-Day Range
10
12.65
52-Week Range
10
23.50
Volume
151,169 shs
Average Volume
274,710 shs
Market Capitalization
£10.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OPTI Stock News Headlines

Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
OptiBiotix Health Share Chat (OPTI)
See More Headlines

OPTI Stock Analysis - Frequently Asked Questions

OptiBiotix Health's stock was trading at GBX 18.05 on January 1st, 2025. Since then, OPTI stock has decreased by 44.6% and is now trading at GBX 10.

OptiBiotix Health Plc (LON:OPTI) announced its quarterly earnings data on Monday, June, 30th. The company reported ($1.84) EPS for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative trailing twelve-month return on equity of 36.76%.

Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that OptiBiotix Health investors own include SkinBioTherapeutics (SBTX), IQE (IQE), Oracle (ORCL), Digital Globe Services (DGS), Derwent London (DLN), Petrofac (PFC) and IP Group (IPO).

Company Calendar

Last Earnings
6/30/2025
Today
9/14/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:OPTI
Previous Symbol
LON:CMI
CIK
N/A
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£3.09 million
Net Margins
-524.43%
Pretax Margin
N/A
Return on Equity
-36.76%
Return on Assets
-13.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.18
Quick Ratio
7.89

Sales & Book Value

Annual Sales
£870 thousand
Price / Sales
11.87
Cash Flow
GBX 1.15 per share
Price / Cash Flow
8.68
Book Value
GBX 7.80 per share
Price / Book
1.28

Miscellaneous

Outstanding Shares
103,300,000
Free Float
N/A
Market Cap
£10.33 million
Optionable
Not Optionable
Beta
1.71
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:OPTI) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners